Article Information
vol. 58 no. suppl 65
Published By
Print ISSN
Online ISSN
History
- Published online November 25, 2021.
Copyright & Usage
Copyright ©the authors 2021
Author Information
- Kenneth R. Chapman1⇑,
- Richard N Van Zyl-Smit2,
- Huib A M Kerstjens3,
- Jorge F Maspero4,
- Motoi Hosoe5,
- Ana-Maria Tanase5,
- Abhijit Pethe6,
- Peter D’Andrea6 and
- Dominic Brittain5
- 1Division of Respiratory Medicine, Department of Medicine, University of Toronto, Toronto (ON), Canada
- 2Division of Pulmonology and UCT Lung Institute, University of Cape Town, Cape Town, South Africa
- 3Department of Pulmonology, University of Groningen, University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, Netherlands
- 4Allergy and Respiratory Research Unit, Fundación Centro Investigacion de Enfermedades Alergicas y Respiratorias, Buenos Aires, Argentina
- 5Novartis Pharma AG, Basel, Switzerland
- 6Novartis Pharmaceuticals Corporation, East Hanover, United States of America
- Kenneth R. Chapman, Division of Respiratory Medicine, Department of Medicine, University of Toronto, Toronto (ON), Canada. E-mail: ken.chapman.airways{at}gmail.com
Article usage
Altmetrics
Vol 58 Issue suppl 65
Table of Contents
Evaluating contributions of mometasone (MF), indacaterol (IND) and glycopyrronium (GLY) to reduction of exacerbations in patients with inadequately controlled asthma: Results from the IRIDIUM study
